Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 7, 2017; 23(25): 4569-4578
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4569
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4569
Figure 3 Effect of miR-29a on HepG2.
2.15 cell viability (n = 3). HepG2.2.15 cells were transfected with miR-control, miR-29a mimics or anti-miR-29a for 48 h. HepG2 cell viability transfected with (A) miR-29a mimics and (B) anti-miR-29a was determined using the CCK-8 assay. Data represent the mean ± SD.
- Citation: Wu HJ, Zhuo Y, Zhou YC, Wang XW, Wang YP, Si CY, Wang XH. miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma. World J Gastroenterol 2017; 23(25): 4569-4578
- URL: https://www.wjgnet.com/1007-9327/full/v23/i25/4569.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i25.4569